Welcome to Pivot Park Screening Centre
We help you to accelerate drug discovery

Pivot Park Screening Centre (PPSC) is your optimal partner in early drug discovery. At PPSC we provide drug discovery services in the fields of assay development, lab automation, Ultra-High-Throughput Screening (uHTS) and hit-to-lead biological profiling, in order to find novel leads for drug development.

We are continuously expanding our early drug discovery know-how, compound library and services to add value to our vibrant client network and the pharmaceutical R&D community. Through this we help you accelerate drug discovery for a healthier society.


PPSC is located at Pivot Park in the Netherlands, which focuses on pharmaceutical R&D. It is an inspiring campus for open innovation in life sciences. 

What makes Pivot Park Screening Centre unique?

  Integrated approach for early drug discovery 

  Handling of large customer compound libraries

  Big pharma-like uHTS set-up and top-notch read-out technologies

  Very experienced screening site for ELF & pharma-accounts

  Broad knowledge in different assay development-solutions

  From disease targets to high-quality starting points for drug development

Interested? Get in touch and we’ll help you accelerate your drug discovery.

Early drug discovery

Discover what we can do for you

Discover our services

We offer services to help you succeed in the early stages of the drug discovery process.

 

 

 

Discover our infrastructure

The Pivot Park Screening Centre (PPSC) is equipped with advanced robotic systems and offers Ultra-High-Throughput Screening (uHTS) and lab automation services to accelerate your drug discovery.

Discover our projects

We work together with our customers and partners on the bases of open communication and trust. 

 

 

 

 

Discover ELF

The European Lead Factory is a
unique public-private partnership that promotes new discoveries via open innovation and crowd sourcing programmes.

 

Some facts & figures about Pivot Park Screening Centre

0 mil.
Compounds screened
0 mil.
Data points in 2022
0
Screens per year
0
Assays per year
0
Hit-to-lead programmes finalized and 6 running in 2022

Blog, News, Events & Stories

Discovery US 2022
Events

Discovery US 2022 in Boston, November 17-18

Join us at Discovery US and network with us and over 350 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry, target identification, validation and HIT optimisation.

Read More »
Five reasons for a startup to outsource a screen at PPSC

Are you a startup?

Read all about the 5 reasons to outsource a screen at PPSC

Is you assay amendable to uHTS? Seven aspects to consider

7 aspects to assess

Is your assay amendable to ultra-High-Throughput Screening?
Seven aspects to consider…

What our clients say

Thank you for you interest!

To download this publication we would like to receive your e-mail. 

Thank you for you interest!

To download this publication we would like to receive your e-mail. 

Thank you for you interest!

To download this publication we would like to receive your e-mail. 

Join us on Linkedin